多不饱和脂肪酸与2型糖尿病关系研究进展

多不饱和脂肪酸与2型糖尿病关系研究进展Researchprogressontherelationshipbetweenpolyunsaturatedfattyacidsandtype2diabetesmellitu

摘要膳食中多不饱和脂肪酸与2型糖尿病的相关研究一直是公共卫生领域的研究热点之一。而目前随着环境变化以及人们生活方式的改变，2型糖尿在我国乃至世界的发病率都呈快速增长趋势，已经成为了不容忽视的重大公共卫生事件。国内外目前也都将膳食疗法作为糖尿病治疗方案必要的选择之一，但目前多不饱和脂肪酸与2型糖尿病的研究还不够明确，存在争议。本文旨在探究多不饱和脂肪酸与2型糖尿病的相关性以及作用机制，有助于2型糖尿病的预防、控制与治疗。关键词多不饱和脂肪酸；2型糖尿病；相关性；机制

AbstractTheresearchontherelationshipbetweendietarypolyunsaturatedfattyacidsandtype2diabeteshasalwaysbeenoneoftheresearchhotspotsinthefieldofpublichealth.Atpresent,withthechangeofenvironmentandthechangeofpeople'slifestyle,theincidenceoftype2glycosuriaisincreasingrapidlyinChinaandevenintheworld,whichhasbecomeamajorpublichealtheventthatcannotbeignored.Atpresent,dietarytherapyisregardedasoneofthenecessarychoicesforthetreatmentofdiabetesathomeandabroad,butthecurrentresearchonpolyunsaturatedfattyacidsandtype2diabetesisnotclearandcontroversial.Thepurposeofthisstudyistoexplorethecorrelationandmechanismbetweenpolyunsaturatedfattyacidsandtype2diabetes,whichishelpfultotheprevention,controlandtreatmentoftype2diabetes.KeywordsPulmonaryFlora；Polyunsaturatedfattyacids;type2diabetesmellitus;correlation;mechanism

目录第1章前言 第2章糖尿病 2.1糖尿病概述 2.22型糖尿病 第3章多不饱和脂肪酸 第4章多不饱和脂肪酸对人群2型糖尿病的影响 4.1对健康人群的影响 4.1.1可降低健康人患2型糖尿病的风险 4.1.2对健康人患2型糖尿病的影响不明显 4.1.3会增加健康人患2型糖尿病的风险 4.2对2型糖尿病病人的影响 4.2.1对糖尿病患者无有益影响 4.2.2对糖尿病患者产生有益影响 第5章多不饱和脂肪酸增加胰岛素敏感性的相关机制 第6章结论与展望 第7章谢辞 第8章参考文献

参考文献[1]BehrouzV,DastkhoshA,SohrabG,Overviewofdietarysupplementsonpatientswithtype2diabetes,Diabetes&MetabolicSyndrome:ClinicalResearch&Reviews(2020),doi:https:///10.1016/j.dsx.2020.03.019.[2]曹星华,姚敏,王瑞英,等.多不饱和脂肪酸增加胰岛素敏感性机制的进展[J].河北医科大学学报,2018,39(4):485-488.[3]寿天星.血浆脂肪酸谱与2型糖尿病表型相关性研究:病例对照研究[D].浙江大学,2012.[4]HuFB.MetabolicProfilingofDiabetes:FromBlack-BoxEpidemiologytoSystemsEpidemiology[J].ClinicalChemistry(9):9.[5]BraynerBárbara,GunveenK,MichelleK,etal.FADSPolymorphism,Omega-3FattyAcidsandDiabetesRisk:ASystematicReview[J].Nutrients,2018,10(6):758-.[6]ZhangY,ZhuangP,MaoL,etal.Currentleveloffishandomega-3fattyacidintakesandriskofType2diabetesinChina[J].JournalofNutritionalBiochemistry,2019,74:108249.[7]中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中国实用内科杂志,2018,v.38(04):34-86.[8]GermánD.Carrasquilla,HerminaJ,TuomasO.K.DietaryFatandtheGeneticRiskofType2Diabetes[J].CurrentDiabetesReports,2019,19:109.[9]刘金泉,冯凭.膳食脂肪酸与肥胖、2型糖尿病和心血管疾病关系的研究进展[J].医学综述,2014,20(20):3760-3762.[10]EvaW,MagdalenaR,Mai-LisH,etal.Associationsbetweenestimatedfattyaciddesaturaseactivitiesinserumlipidsandadiposetissueinhumans:linkstoobesityandinsulinresistance[J].LipidsinHealthandDisease,2009,doi:10.1186/1476-511X-8-37.[11]PottelL,LyckeM,BoterbergT,etal.Omega-3fattyacids:physiology,biologicalsourcesandpotentialapplicationsinsupportivecancercare[J].PhytochemistryReviews,2014,13(1):223-244.[12]阮悦.膳食n-3多不饱和脂肪酸干预对2型糖尿病患者尿液小分子代谢物的影响[D].2019.[13]吴育红,张爱珍,李铎.2型糖尿病患者血浆磷脂脂肪酸谱与胰岛素抵抗[J].中国全科医学,2008,11(17).[14]P.Golpour,M.Nourbakhsh,M.Mazaherioun,L.Janani,M.Nourbakhsh,P.Yaghmaei,ImprovementofNrf2geneexpressionandantioxidantstatusinpatientswithtype2diabetesmellitusaftersupplementationwithomega-3polyunsaturatedfattyacids:adouble-blindrandomisedplacebo-controlledclinicaltrial,DiabetesResearchandClinicalPractice(2020),doi:/10.1016/j.diabres.2020.108120[15]王锋,柳和春,刘小松,等.不同来源ω-3多不饱和脂肪酸对2型糖尿病合并血脂异常人群糖脂代谢的影响[J].中华预防医学杂志,2019,53(6):570-575.[16]FayhAPT,BorgesK,CunhaGS,etal.Effectsofn-3fattyacidsandexerciseonoxidativestressparametersintype2diabetic:Arandomizedclinicaltrial[J].JournaloftheInternationalSocietyofSportsNutrition,2018,15(1):18.[17]RossmeislM,PavlisovaJ,JanovskaP,etal.Differentialmodulationofwhiteadiposetissueendocannabinoidlevelsbyn-3fattyacidsinobesemiceandtype2diabeticpatients[J].BiochimicaetBiophysicaActa(BBA)-MolecularandCellBiologyofLipids,2018:S1388198118300520.[18]StorlienL,KraegenE,ChisholmD,etal.Fishoilpreventsinsulinresistanceinducedbyhigh-fatfeedinginrats[J].Science,1987,237(4817):885-888.[19]LeonardHStorlien,ArthurBJenkins,DonaldJChisholm,etal.InfluenceofDietaryFatCompositiononDevelopmentofInsulinResistanceinRats:RelationshiptoMuscleTriglycerideandω-3FattyAcidsinMusclePhospholipid[J].diabetes,1991,40(2):280-289.[20]Egert,Sarah,Fobker,etal.EffectsofDietaryα-LinolenicAcid,EicosapentaenoicAcidorDocosahexaenoicAcidonParametersofGlucoseMetabolisminHealthyVolunteers.[J].AnnalsofNutrition&Metabolism,2009.[21]FaschingP,RatheiserK,WaldhauslW,etal.MetabolicEffectsofFish-OilSupplementationinPatientsWithImpairedGlucoseTolerance[J].Diabetes,1991,40(5):583-589.[22]ToftI,BonaaKH,IngebretsenOC,NordoyA,JenssenT.Effectsofn-3polyunsaturatedfattyacidsonglucosehomeostasisandbloodpressureinessentialhypertension.Arandomized,controlledtrial.AnnInternMed1995;123:911–8.[23]AdlerAI,BoykoEJ,SchraerCD,etal.LowerPrevalenceofImpairedGlucoseToleranceandDiabetesAssociatedWithDailySealOilorSalmonConsumptionamongAlaskaNatives[J].DiabetesCare,1994,17(12):1498-1501.[24]FeskensEJ,BowlesCH,KromhoutD.InverseAssociationBetweenFishIntakeandRiskofGlucoseIntoleranceinNormoglycemicElderlyMenandWomen[J].DiabetesCare,1991,14(11):935-941.[25]MeyerKA,KushiLH,JacobsDR,etal.DietaryFatandIncidenceofType2DiabetesinOlderIowaWomen[J].DiabetesCare,2001,24(9):1528-1535.[26]Salmerón,Jorge,HuFB,MansonJAE,etal.Dietaryfatintakeandriskoftype2diabetesinwomen[J].AmericanJournalofClinicalNutrition,2001,73(6):1019-1026.[27]PinalSP,SheilaAB,etal.AssociationBetweenTypeofDietaryFishandSeafoodIntakeandtheRiskofIncidentType2Diabetes.[J].DiabetesCare,2009.[28]DjousseL,BiggsML,LemaitreRN,etal.Plasmaomega-3fattyacidsandincidentdiabetesinolderadults[J].TheAmericanJournalofClinicalNutrition(2):2.[29]AkikoN,TetsuyaM,MitsuhikoN,etal.Fishintakeandtype2diabetesinJapanesemenandwomen:theJapanPublicHealthCenter–basedProspectiveStudy[J].TheAmericanJournalofClinicalNutrition(3):3.[30]RaquelV,Yong-BingX,TomE,etal.Fish,shellfish,andlong-chainn−3fattyacidconsumptionandriskofincidenttype2diabetesinmiddle-agedChinesemenandwomen[J].TheAmericanJournalofClinicalNutrition(2):2.[31]Diana,P,Brostow,etal.Omega-3fattyacidsandincidenttype2diabetes:theSingaporeChineseHealthStudy.[J].AmericanJournalofClinicalNutrition,2011.[32]GIACCO,Rosalba,CUOMO,etal.Fishoil,insulinsensitivity,insulinsecretionandglucosetoleranceinhealthypeople:Isthereanyeffectoffishoilsupplementationinrelationtothetypeofbackgrounddietandhabitualdietaryintakeofn-6andn-3fattyacids?[J].nutritionmetabolism&cardiovasculardiseasesnmcd,2007,17(8):572-580.[33]ManasK,DariushM,DonnaS,etal.Long-chainomega-3fattyacids,fishintake,andtheriskoftype2diabetesmellitus[J].TheAmericanJournalofClinicalNutrition(3):3.[34]LucDjoussé,JMichaelGaziano,JulieEBuring,etal.Dietaryomega-3fattyacidsandfishconsumptionandriskoftype2diabetes1,2,3,4[J].americanjournalofclinicalnutrition,2010,93(1):143-150.[35]VanWoudenberghGJ,VanBallegooijenAJ,KuijstenA,etal.EatingFishandRiskofType2Diabetes:Apopulation-based,prospectivefollow-upstudy[J].DiabetesCare,2009,32(11):2021-2026.[36]Lee,Duk-Hee,In-Kyu,etal.AStrongDose-ResponseRelationBetweenSerumConcentrationsofPersistentOrganicPollutantsandDiabetes.[J].DiabetesCare,2006.[37]MozaffarianD,RimmEB.FishIntake,Contaminants,andHumanHealth:EvaluatingtheRisksandtheBenefits[J].JournaloftheAmericanMedicalAssociation,296.[38]WoodmanRJ,MoriTA,BurkeV,PuddeyIB,WattsGF,BeilinLJ.Effectsofpurifiedeicosapentaenoicanddocosahexaenoicacidsonglycemiccontrol,bloodpressure,andserumlipidsintype2diabeticpatientswithtreatedhypertension.AmJClinNutr2002;76:1007–15.[39]MostadIL,BjerveKS,BjorgaasMR,etal.Effectsofn−3fattyacidsinsubjectswithtype2diabetes:reductionofinsulinsensitivityandtime-dependentalterationfromcarbohydratetofatoxidation[J].TheAmericanJournalofClinicalNutrition(3):3.[40]MostadIL,BjerveKS,BjorgaasMR,etal.Effectsofn−3fattyacidsinsubjectswithtype2diabetes:reductionofinsulinsensitivityandtime-dependentalterationfromcarbohydratetofatoxidation[J].TheAmericanJournalofClinicalNutrition(3):3.[41]FallowGD,SinghJ.Theprevalence,typeandseverityofcardiovasculardiseaseindiabeticandnon-diabeticpatients:Amatched-pairedretrospectiveanalysisusingcoronaryangiographyasthediagnostictool[J].Molecular&CellularBiochemistry,2004,261(1):263-269.[42]StrandE,PedersenER,SvingenGF,etal